Real-world Dapagliflozin Treatment in Patients With Heart Failure in Portugal (EVOLUTION-HF)
Clinical trial NCT05465213 · COMPLETED
Trial details
- NCT number
- NCT05465213
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-28
- Primary completion
- 2024-06-24
- Enrollment
- 283
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.